Related Experiment Video
Updated: May 5, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
20.3K
Antiretroviral therapy and tuberculosis: does the regimen matter?
Frank van Leth1, Ferdinand W N M Wit, Sabine M Hermans
1Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.
Expert Review of Anti-Infective Therapy
|November 22, 2013
Summary
Combination antiretroviral therapy (cART) reduces tuberculosis incidence in HIV patients. However, data are scarce on whether the initial drug choice impacts this effect, limiting recommendations.
Area of Science:
- Infectious Diseases
- Immunology
- Public Health
Background:
- HIV infection is a primary driver of tuberculosis incidence globally.
- Combination antiretroviral therapy (cART) is known to reduce tuberculosis incidence in HIV-infected individuals.
Discussion:
- Limited data exist on whether specific initial antiretroviral drug types or regimens differentially affect tuberculosis incidence.
- Many studies are not designed to assess cART's impact on tuberculosis incidence or lack validated tuberculosis diagnoses.
Key Insights:
- The specific choice of initial cART regimen for preventing tuberculosis in HIV patients is not clearly established due to insufficient evidence.
- Existing evidence suggests that other interventions, such as tuberculosis preventive therapy and early initiation of cART, are more impactful for prevention.
Outlook:
- Further research is needed to determine if initial cART regimens influence tuberculosis incidence.
- Focusing on preventive therapy and early cART initiation may be more effective strategies for tuberculosis prevention in HIV-positive populations.
Related Concept Videos
01:28Pulmonary Tuberculosis V
1.0K
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
1.0K
01:29Pulmonary Tuberculosis I
1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
01:10Retrovirus Life Cycles
43.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.1K
01:26Pulmonary Tuberculosis IV
844
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
844
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
413
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
413
01:29Therapeutic Drug Monitoring: Affecting Factors
438
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
438